Vaxcyte Appoints John Furey to Board of Directors
July 02, 2024 08:30 ET
|
Vaxcyte, Inc.
Vaxcyte appoints John Furey to Board of Directors.
Global Vaccine Partnering Deals Analysis Report and Directory 2016-2024: Collaboration, Development, Research and Licensing Deals by Company A-Z, Deal Type and Therapy Area
June 25, 2024 11:22 ET
|
Research and Markets
Dublin, June 25, 2024 (GLOBE NEWSWIRE) -- The "Vaccine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.Vaccine Collaboration and Licensing...
AstriVax enters clinical phase with its novel vaccine platform technology
June 24, 2024 01:00 ET
|
AstriVax
The first participants have been dosed in SAFYR, a Phase I clinical trial to test the safety and efficacy of two prophylactic vaccines developed with AstriVax technology. The study will also provide...
Vaccine Contract Manufacturing Market Report 2024-2030: Discover the Trends and Drivers Shaping the Global Landscape
June 17, 2024 04:20 ET
|
Research and Markets
Dublin, June 17, 2024 (GLOBE NEWSWIRE) -- The "Vaccine Contract Manufacturing - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
Global Vaccines (Monovalent, Multivalent) Market Research Report 2024-2028: $94.9 Billion Market Analysis by Technology, Disease, Route of Administration
June 05, 2024 04:25 ET
|
Research and Markets
Dublin, June 05, 2024 (GLOBE NEWSWIRE) -- The "Global Vaccines Market by Technology (Conjugate, Recombinant, Live Attenuated, Toxoid, Viral Vector, mRNA), Type (Monovalent, Multivalent), Disease...
Global Anti-Venom Market Report 2024-2032, by Species, Anti-venom Type, Mode of Action, End User and Region - A $2 Billion Market by 2032
June 04, 2024 12:37 ET
|
Research and Markets
Dublin, June 04, 2024 (GLOBE NEWSWIRE) -- The "Global Anti-Venom Market Report by Species, Anti-venom Type, Mode of Action, End User, and Region 2024-2032" report has been added to ...
Allergy Vaccine Market Trends, Forecast and Competitive Analysis: A $3.6 Billion Market by 2030 with a CAGR of 7.5% from 2024 to 2030
May 31, 2024 04:18 ET
|
Research and Markets
Dublin, May 31, 2024 (GLOBE NEWSWIRE) -- The "Allergy Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's offering.The global...
Meningococcal Vaccines Analysis Report 2024: A $3.1 Billion Market by 2024 - Simplifying Regulatory Procedures to Accelerate Vaccine R&D
May 29, 2024 04:14 ET
|
Research and Markets
Dublin, May 29, 2024 (GLOBE NEWSWIRE) -- The "Meningococcal Vaccines Market Report 2024-2034" report has been added to ResearchAndMarkets.com's offering.Meningococcal Vaccines Market will surpass...
Global Vaccine Delivery Devices Market Analysis & Forecast 2024-2034
May 27, 2024 04:01 ET
|
Research and Markets
Dublin, May 27, 2024 (GLOBE NEWSWIRE) -- The "Global Vaccine Delivery Devices Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering.The global...
Dyadic Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress
May 14, 2024 16:00 ET
|
Dyadic International, Inc.
Human Health Sector Final Clinical Study Report has been issued for the First-In-Human Phase 1 clinical trial demonstrating safety and antibody response for DYAI-100, a recombinant...